Back to calendar
AbCellera Biologics Inc. (ABCL) Earnings
ABCL reports earnings on Wednesday, August 5, 2026
earnings report
August 5, 2026 · After Market Close
Q2 2026
Est. EPS: $-0.17
Actual EPS: $-0.18
EPS surprise: -9.76%
Company overview
Market Cap$2.1B
PriceUSD 6.93
EPS (TTM)-0.54
52-week high8.44
52-week low2.75
SectorHealth Technology
IndustryBiotechnology
Employees562